BLUE SAIL MEDICAL(SZ:002382) Sou Hu Cai Jing·2025-09-12 13:03Core Viewpoint - Bluefan Medical (002382) has shown a decline in stock price and financial performance, indicating potential challenges in the medical device industry [1][3]. Financial Performance - As of September 12, 2025, Bluefan Medical's stock closed at 5.92 yuan, down 0.34% with a trading volume of 66,900 shares and a turnover of 39.51 million yuan [1]. - The company's mid-year report for 2025 revealed a main revenue of 2.781 billion yuan, a year-on-year decrease of 7.49%, and a net profit attributable to shareholders of -135 million yuan, a year-on-year increase of 15.88% [3]. - The second quarter of 2025 saw a single-quarter main revenue of 1.303 billion yuan, down 16.0% year-on-year, and a net profit of -212 million yuan, a significant decline of 245.53% year-on-year [3]. Market Position and Ratios - Bluefan Medical's total market value is 5.942 billion yuan, ranking 60th in the medical device industry, which has an average market value of 12.221 billion yuan [3]. - The company has a net asset of 9.905 billion yuan, significantly higher than the industry average of 3.889 billion yuan, ranking 7th [3]. - The price-to-earnings ratio (P/E) is -22.04, while the industry average is 69.76, indicating a challenging profitability outlook [3]. - The company's gross margin is 14.34%, compared to the industry average of 51.85%, ranking 120th [3]. Capital Flow Analysis - On September 12, 2025, the net outflow of main funds was 8.6612 million yuan, accounting for 17.13% of the total turnover, while retail investors saw a net inflow of 4.6122 million yuan, representing 9.12% of the total turnover [1][2]. - Over the past five days, the stock has experienced fluctuations in capital flow, with notable net outflows on September 9, amounting to 20.2714 million yuan, which was 26.09% of the total turnover [2].